Literature DB >> 22791200

Surgical treatment of carotid in-stent-restenosis: novel strategy and current management.

Dominik Jost1, Susanne Johanna Unmuth, Helfried Meissner, Albrecht Henn-Beilharz, Hans Henkes, Thomas Hupp.   

Abstract

BACKGROUND: Associated with increasing use of carotid artery stenting (CAS), the occurrence of late complications is likely to rise. The surgical strategies of CAS complications like in-stent-restenosis (ISR) are not yet to be determined. Thus different situations require individual operative techniques. This study contains our experience in the operative management for significant recurrent carotid stenosis following angioplasty and stent placement. As a novel strategy, we report successful stent removal and endarterectomy with eversion technique (ECEA).
METHODS: Four complete stent removals were performed in three patients with three different techniques and anesthesiological protocols (general anesthesia n = 1, regional anesthesia n = 3). First stent removal with excision of common carotid artery (CCA) and internal carotid artery (ICA) following interposition of CCA-ICA with Dacron graft (n = 1). Second carotid endarterectomy with stent removal followed by patch angioplasty (n = 2). Third stent removal and ECEA and thus biological reconstruction without synthetic material (n = 1). Mean operative time was 131 minutes (±19.25). Mean follow-up was 11.5 months (±7.7). As postoperative complications, one major bleeding, one transient neurologic deficit and one postoperative neck hematoma, requiring operative revision, occurred. During a 30-day follow-up, all patients made an uneventful recovery. There was no evidence of restenosis or neurological deficit during the following postoperative controls. A review and comparison of the current surgical management and strategies in the treatment of ISR was also performed (Pubmed).
CONCLUSION: Surgical treatment of ISR after CAS is beneficial but in literature infrequently reported. We could demonstrate in this study that even stent removal and ECEA is feasible and safe with durable outcome. The current strategies are therefore extended as well as the reported performance under regional anesthesia. However, surgical treatment in ISR remains a challenging option and larger series are highly recommended. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2012        PMID: 22791200     DOI: 10.1055/s-0032-1311535

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  4 in total

1.  Crosstalk between TGF-β/Smad3 and BMP/BMPR2 signaling pathways via miR-17-92 cluster in carotid artery restenosis.

Authors:  Tao Luo; Shijun Cui; Chunjing Bian; Xiaochun Yu
Journal:  Mol Cell Biochem       Date:  2013-12-31       Impact factor: 3.396

2.  Successful treatment of recurrent carotid in-stent restenosis and drug-eluting balloon failure with a coronary bioresorbable vascular scaffold: A case report.

Authors:  Arturo Giordano; Paolo Ferraro; Nicola Corcione; Stefano Messina; Gennaro Maresca; Enrico Coscioni; Giuseppe Biondi-Zoccai
Journal:  Int J Surg Case Rep       Date:  2016-02-27

3.  Carotid endarterectomy for treatment of carotid in-stent restenosis: long-term follow-up results and surgery experiences from one single centre.

Authors:  Le-Bao Yu; Wei Yan; Qian Zhang; Ji-Zong Zhao; Yan Zhang; Rong Wang; Jun-Shi Shao; Dong Zhang
Journal:  Stroke Vasc Neurol       Date:  2017-08-24

Review 4.  The management of carotid restenosis: a comprehensive review.

Authors:  Francesco Stilo; Nunzio Montelione; Rosalinda Calandrelli; Marisa Distefano; Francesco Spinelli; Vincenzo Di Lazzaro; Fabio Pilato
Journal:  Ann Transl Med       Date:  2020-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.